Bluejay Diagnostics, Inc. (BJDX)
1.899
-0.06
(-3.11%)
USD |
NASDAQ |
Apr 24, 16:00
1.92
+0.02
(+1.12%)
After-Hours: 20:00
Bluejay Diagnostics Shareholders Equity (Quarterly) : 5.975M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 527.16M |
| Plus Therapeutics, Inc. | 3.996M |
| Atossa Therapeutics, Inc. | 39.35M |
| Abeona Therapeutics, Inc. | 159.22M |
| Cell Source, Inc. | -18.54M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.119M |
| Total Liabilities (Quarterly) | 1.144M |
| Debt to Equity Ratio | 0.0217 |
| Current Ratio | 4.882 |
| Net Debt Paydown Yield | 1.57% |